The challenge in professionalizing bioethics is to retain interdisciplinary membership and exchange as an integral part of the profession.

Successful telemedicine ethics consultation requires knowledge of relevant laws and, for videoconferences, the physical presence of a meeting leader.

In the 1910s, the American Medical Association fought quackery promoted in pamphlets for drugs and treatments for everything from teething to epilepsy.

Telemedicine is fast becoming a reliable medium for convening ethics deliberations and bringing expert assistance to remote locations.

Minimizing and managing risks of ENMs means considering whether and when existing legal frameworks offer sufficient protection.

Nanoscale products pose ethical, legal, and policy challenges to governing the use of products that integrate multiple mechanisms of therapeutic action.

Strategies for improving health care ethics consultation should appeal to key stakeholders in hospitals and not just the academic bioethics community.

Prevention efforts can marginalize patients by stigmatizing certain behaviors, so distinguishing individual professionals’ preferences about those behaviors is critical.

Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation.

Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions.